🇺🇸 FDA
Patent

US 7329759

Illudin analogs useful as antitumor agents

granted A61PA61P35/00A61P35/04

Quick answer

US patent 7329759 (Illudin analogs useful as antitumor agents) held by The Regents of the University of California expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P35/00, A61P35/04